» Articles » PMID: 34203921

From Sampling to Sequencing: A Liquid Biopsy Pre-Analytic Workflow to Maximize Multi-Layer Genomic Information from a Single Tube

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Jul 2
PMID 34203921
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Liquid biopsies hold great promise for the management of cancer. Reliable liquid biopsy data depend on stable and reproducible pre-analytical protocols that comply with quality measures, irrespective of the sampling and processing site. We established a workflow for plasma preservation, followed by processing, cell-free nucleic acid isolation, quantification, and enrichment of potentially tumor-derived cell-free DNA and RNA. Employing the same input material for a direct comparison of different kits and protocols allowed us to formulate unbiased recommendations for sample collection, storage, and processing. The presented workflow integrates the stabilization in Norgen, PAX, or Streck tubes and subsequent parallel isolation of cell-free DNA and RNA with NucleoSnap and NucleoSpin. Qubit, Bioanalyzer, and TapeStation quantification and quality control steps were optimized for minimal sample use and high sensitivity and reproducibility. We show the efficiency of the proposed workflow by successful droplet digital PCR amplification of both cell-free DNA and RNA and by detection of tumor-specific alterations in low-coverage whole-genome sequencing and DNA methylation profiling of plasma-derived cell-free DNA. For the first time, we demonstrated successful parallel extraction of cell-free DNA and RNA from plasma samples. This workflow paves the road towards multi-layer genomic analysis from one single liquid biopsy sample.

Citing Articles

Targeted detection of sequence variants in cell-free DNA from cerebrospinal fluid in pediatric central nervous system tumors.

OHalloran K, Crotty E, Christodoulou E, Leary S, Miller A, Paulson V Front Oncol. 2025; 14():1513073.

PMID: 39834946 PMC: 11743934. DOI: 10.3389/fonc.2024.1513073.


Establishment of liquid biopsy procedure for the analysis of circulating cell free DNA, exosomes, RNA and proteins in colorectal cancer and adenoma patients.

ceri A, Somborac-Bacura A, Fabijanec M, Hulina-Tomaskovic A, Matusina M, Detel D Sci Rep. 2024; 14(1):26925.

PMID: 39506031 PMC: 11541997. DOI: 10.1038/s41598-024-78497-x.


Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm.

Arthur C, Carlson L, Svoboda J, Sandvik U, Jylha C, Nordenskjold M NPJ Precis Oncol. 2024; 8(1):44.

PMID: 38388693 PMC: 10884019. DOI: 10.1038/s41698-024-00535-8.


Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.

Sundby R, Rhodes S, Komlodi-Pasztor E, Sarnoff H, Grasso V, Upadhyaya M Clin Trials. 2023; 21(1):40-50.

PMID: 37904489 PMC: 10922556. DOI: 10.1177/17407745231203330.


Benefits of applying molecular barcoding systems are not uniform across different genomic applications.

Bieler J, Kubik S, Macheret M, Pozzorini C, Willig A, Xu Z J Transl Med. 2023; 21(1):305.

PMID: 37147717 PMC: 10163729. DOI: 10.1186/s12967-023-04160-0.


References
1.
Grolz D, Hauch S, Schlumpberger M, Guenther K, Voss T, Sprenger-Haussels M . Liquid Biopsy Preservation Solutions for Standardized Pre-Analytical Workflows-Venous Whole Blood and Plasma. Curr Pathobiol Rep. 2019; 6(4):275-286. PMC: 6290703. DOI: 10.1007/s40139-018-0180-z. View

2.
McEwen A, Leary S, Lockwood C . Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors. Front Cell Dev Biol. 2020; 8:45. PMC: 7039816. DOI: 10.3389/fcell.2020.00045. View

3.
Cohen J, Li L, Wang Y, Thoburn C, Afsari B, Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018; 359(6378):926-930. PMC: 6080308. DOI: 10.1126/science.aar3247. View

4.
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer F, Hesch R . DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001; 61(4):1659-65. View

5.
Samejima K, Earnshaw W . Trashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol. 2005; 6(9):677-88. DOI: 10.1038/nrm1715. View